DNTH Long Call Strategy
DNTH (Dianthus Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.
DNTH (Dianthus Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.58B, a beta of 0.09 versus the broader market, a 52-week range of 16.64-96.5, average daily share volume of 958K, a public-listing history dating back to 2018, approximately 78 full-time employees. These structural characteristics shape how DNTH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.09 indicates DNTH has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on DNTH?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current DNTH snapshot
As of May 15, 2026, spot at $86.15, ATM IV 57.70%, IV rank 2.26%, expected move 16.54%. The long call on DNTH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 98-day expiry.
Why this long call structure on DNTH specifically: DNTH IV at 57.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a DNTH long call, with a market-implied 1-standard-deviation move of approximately 16.54% (roughly $14.25 on the underlying). The 98-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DNTH expiries trade a higher absolute premium for lower per-day decay. Position sizing on DNTH should anchor to the underlying notional of $86.15 per share and to the trader's directional view on DNTH stock.
DNTH long call setup
The DNTH long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DNTH near $86.15, the first option leg uses a $85.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DNTH chain at a 98-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DNTH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $85.00 | $14.15 |
DNTH long call risk and reward
- Net Premium / Debit
- -$1,415.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$1,415.00
- Breakeven(s)
- $99.15
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
DNTH long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on DNTH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$1,415.00 |
| $19.06 | -77.9% | -$1,415.00 |
| $38.10 | -55.8% | -$1,415.00 |
| $57.15 | -33.7% | -$1,415.00 |
| $76.20 | -11.6% | -$1,415.00 |
| $95.25 | +10.6% | -$390.43 |
| $114.29 | +32.7% | +$1,514.28 |
| $133.34 | +54.8% | +$3,418.99 |
| $152.39 | +76.9% | +$5,323.71 |
| $171.43 | +99.0% | +$7,228.42 |
When traders use long call on DNTH
Long calls on DNTH express a bullish thesis with defined risk; traders use them ahead of DNTH catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
DNTH thesis for this long call
The market-implied 1-standard-deviation range for DNTH extends from approximately $71.90 on the downside to $100.40 on the upside. A DNTH long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current DNTH IV rank near 2.26% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on DNTH at 57.70%. As a Healthcare name, DNTH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DNTH-specific events.
DNTH long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DNTH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DNTH alongside the broader basket even when DNTH-specific fundamentals are unchanged. Long-premium structures like a long call on DNTH are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current DNTH chain quotes before placing a trade.
Frequently asked questions
- What is a long call on DNTH?
- A long call on DNTH is the long call strategy applied to DNTH (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With DNTH stock trading near $86.15, the strikes shown on this page are snapped to the nearest listed DNTH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are DNTH long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the DNTH long call priced from the end-of-day chain at a 30-day expiry (ATM IV 57.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,415.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a DNTH long call?
- The breakeven for the DNTH long call priced on this page is roughly $99.15 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DNTH market-implied 1-standard-deviation expected move is approximately 16.54%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on DNTH?
- Long calls on DNTH express a bullish thesis with defined risk; traders use them ahead of DNTH catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current DNTH implied volatility affect this long call?
- DNTH ATM IV is at 57.70% with IV rank near 2.26%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.